Loading...
XLON
EDEN
Market cap25mUSD
Oct 09, Last price  
2.35GBP
1D
0.00%
1Q
-15.79%
Jan 2017
-79.10%
IPO
-87.67%
Name

Eden Research PLC

Chart & performance

D1W1MN
XLON:EDEN chart
P/E
—
P/S
4.86
EPS
—
Div yield, %
—
Shrs. gr., 5y
9.42%
Rev. gr., 5y
23.18%
Revenues
4m
-9.78%
102,559360,78884,003193,000172,00091,00043,59080,22399,855883,312391,9581,877,1872,774,2721,825,5011,368,9881,228,5801,827,1713,192,0274,302,6033,881,812
Net income
-2m
L+2.67%
-4,092,332-2,463,869-2,101,237-1,727,000-3,251,000-3,284,000-2,317,134-1,587,909-2,969,468-1,157,103-1,831,092-639,093-334,951-1,144,703-2,270,347-2,788,973-2,237,262-6,494,249-1,906,591-1,957,518
CFO
-2m
L+141.97%
-1,262,553-228,585-1,280,866-432,000-1,751,000-2,628,000-1,621,505-1,245,977-930,295-104,861-805,789230,041-701,678-1,013,299-1,015,309-1,618,558-683,095-1,695,411-1,008,569-2,440,446

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Eden BioSolutions Plc offers sustainable solutions for crop protection, animal health and consumer products in the United Kingdom and rest of Europe. The firm provides various plant protection products, such as foliar disease control, soil pest, protected glass house crops, and post-harvest applications. It also offers treatment for various pathogens that effect animal health, as well as provides animal health products, such as shampoos, conditioners, odour controls, flea and tick controls, hygiene products, parasite treatments, and insect sprays. The company also offers human health products comprising head-lice, fragrances, wound-care, and food flavorings. It provides a range of natural and synthetic active ingredients, including pesticides, as well as biocides. The company was founded on June 22, 1995 and is headquartered in Abingdon, the United Kingdom.

Key people

Tom G. Lupton
Non-Executive Chairman of the Board · since 2014
Alex J. Abrey
Chief Financial Officer, Executive Director · since 2009
Sean M Smith
Chief Executive Officer, Executive Director · since 2014
Michael Carroll
Director of Regulatory Affairs · since 2020
Robin E. Sims
Company Secretary
IPO date
May 11, 2012
Employees
19
Domiciled in
GB
Incorporated in
GB
Legal address
6, PRIORY COURT
PRIORY COURT BUSINESS PARK
CIRENCESTER, GLS GL7 5JB
GB
Headquarters
6, PRIORY COURT
PRIORY COURT BUSINESS PARK
Poulton
CIRENCESTER, GLS GL7 5JB
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT